McKesson Corporation (NYSE: MCK) Stock Competitors & Peer Comparison

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, COR has a market cap of 62.6B. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while COR trades at $321.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas COR's P/E ratio is 18.75. In terms of profitability, MCK's ROE is -1.94%, compared to COR's ROE of +1.06%. Regarding short-term risk, MCK is less volatile compared to COR. This indicates lower risk in terms of short-term price fluctuations for MCK.Check COR's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, CAH has a market cap of 54.9B. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while CAH trades at $234.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas CAH's P/E ratio is 22.49. In terms of profitability, MCK's ROE is -1.94%, compared to CAH's ROE of -0.60%. Regarding short-term risk, MCK is less volatile compared to CAH. This indicates lower risk in terms of short-term price fluctuations for MCK.Check CAH's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while ABC trades at $179.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas ABC's P/E ratio is 21.92. In terms of profitability, MCK's ROE is -1.94%, compared to ABC's ROE of +1.06%. Regarding short-term risk, MCK is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for MCK.Check ABC's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, HSIC has a market cap of 10.1B. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while HSIC trades at $88.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas HSIC's P/E ratio is 16.64. In terms of profitability, MCK's ROE is -1.94%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, MCK is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for MCK.Check HSIC's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while PDCO trades at $31.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas PDCO's P/E ratio is 20.48. In terms of profitability, MCK's ROE is -1.94%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, MCK is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for MCK.Check PDCO's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, AHG has a market cap of 678.6M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while AHG trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas AHG's P/E ratio is -3.72. In terms of profitability, MCK's ROE is -1.94%, compared to AHG's ROE of -0.50%. Regarding short-term risk, MCK is less volatile compared to AHG. This indicates lower risk in terms of short-term price fluctuations for MCK.Check AHG's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while OMI trades at $2.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas OMI's P/E ratio is -0.47. In terms of profitability, MCK's ROE is -1.94%, compared to OMI's ROE of +0.63%. Regarding short-term risk, MCK is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for MCK.Check OMI's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, EMPG has a market cap of 143M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while EMPG trades at $17.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas EMPG's P/E ratio is 192.89. In terms of profitability, MCK's ROE is -1.94%, compared to EMPG's ROE of +0.66%. Regarding short-term risk, MCK is more volatile compared to EMPG. This indicates higher risk in terms of short-term price fluctuations for MCK.Check EMPG's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, ACH has a market cap of 82.7M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while ACH trades at $1.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas ACH's P/E ratio is 1.59. In terms of profitability, MCK's ROE is -1.94%, compared to ACH's ROE of +0.63%. Regarding short-term risk, MCK is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for MCK.Check ACH's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while HX trades at $2.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas HX's P/E ratio is -1.84. In terms of profitability, MCK's ROE is -1.94%, compared to HX's ROE of -1.07%. Regarding short-term risk, MCK is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for MCK.Check HX's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, YI has a market cap of 31.1M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while YI trades at $3.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas YI's P/E ratio is -2.54. In terms of profitability, MCK's ROE is -1.94%, compared to YI's ROE of +0.14%. Regarding short-term risk, MCK is less volatile compared to YI. This indicates lower risk in terms of short-term price fluctuations for MCK.Check YI's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while WGRX trades at $3.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas WGRX's P/E ratio is -0.33. In terms of profitability, MCK's ROE is -1.94%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, MCK is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for MCK.Check WGRX's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while ZYXI trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, MCK's ROE is -1.94%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, MCK is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for MCK.Check ZYXI's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, MEDS has a market cap of 2.4M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while MEDS trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas MEDS's P/E ratio is N/A. In terms of profitability, MCK's ROE is -1.94%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, MCK is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for MCK.Check MEDS's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, HKPD has a market cap of 1.3M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while HKPD trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas HKPD's P/E ratio is -2.04. In terms of profitability, MCK's ROE is -1.94%, compared to HKPD's ROE of -0.15%. Regarding short-term risk, MCK is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for MCK.Check HKPD's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, SNYR has a market cap of 1.1M. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while SNYR trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas SNYR's P/E ratio is -0.07. In terms of profitability, MCK's ROE is -1.94%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, MCK is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for MCK.Check SNYR's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, RDGT has a market cap of 745.1K. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while RDGT trades at $0.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas RDGT's P/E ratio is -0.02. In terms of profitability, MCK's ROE is -1.94%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, MCK is less volatile compared to RDGT. This indicates lower risk in terms of short-term price fluctuations for MCK.Check RDGT's competition here

McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 103.2B. In comparison, CVET has a market cap of 0. Regarding current trading prices, MCK is priced at $881.51 on the NYSE, while CVET trades at $20.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 21.59, whereas CVET's P/E ratio is -69.97. In terms of profitability, MCK's ROE is -1.94%, compared to CVET's ROE of -0.06%. Regarding short-term risk, MCK is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for MCK.Check CVET's competition here